ANTIPHOSPHOLIPID ANTIBODY - ANVISA Registration 10230730162

Access comprehensive regulatory information for ANTIPHOSPHOLIPID ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10230730162 and manufactured by CORGENIX, INC. The registration is held by NL COMÉRCIO EXTERIOR LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10230730162
Registration Details
ANVISA Registration Number: 10230730162
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Corgenix Anti-Phosphatidylserine IgA Semi-Quantitative Test Kit
Risk Class II

Registration Details

10230730162

25351129983202220

52541273000147

Company Information

CORGENIX, INC
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 07, 2022

VIGENTE

09/18/2025 19:00:01